Pacific Edge's APAC operations advancing towards profit with cancer test growth
Pacific Edge APAC business is advancing towards profitability on a direct-cost basis with a growing interest in its testing services.
Market Cap $64.79M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 11.55am 14/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 31.0¢ | Day High | 39.5¢ | Day Low | 31.0¢ | |||
| Daily Volume | 446656 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 36.0¢ | 3191 | 0 | 36.5¢ | 5500 | |
Directors & Senior Management
| Dr. Alexander Hall | Founder & CTO |
| Dr. Andrew Windsor | Non-Executive Chairman |
| Mr. Blake Burton | Independent Non-Executive Director |
| Mr. Jason Henry | Chief Operating Officer |
| Mr. Justin Olde | MD, CEO & Director |
| Ms. Kyla Garic | Company Secretary |
| Mr. Michael Sinkowitsch | Executive Director |
| Ms. Wilamina Russo | Investor & Media Relations Manager |
Data source: ADVFN
